|
1
|
Ehrhart NP, Ryan SD and Fan TM: Tumors of
the skeletal system. Withrow and MacEwen's Small Animal Clinical
Oncology. Withrow SJ, Vail DM and Page RL: (5th). W.B. Saunders.
(St. Louis, MO). 463–503. 2013. View Article : Google Scholar
|
|
2
|
Mueller F, Fuchs B and Kaser-Hotz B:
Comparative biology of human and canine osteosarcoma. Anticancer
Res. 27:155–164. 2007.PubMed/NCBI
|
|
3
|
Ramirez O III, Dodge RK, Page RL, Price
GS, Hauck ML, LaDue TA, Nutter F and Thrall DE: Palliative
radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol
Ultrasound. 40:517–522. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Green EM, Adams WM and Forrest LJ: Four
fraction palliative radiotherapy for osteosarcoma in 24 dogs. J Am
Anim Hosp Assoc. 38:445–451. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coomer A, Farese J, Milner R, Liptak J,
Bacon N and Lurie D: Radiation therapy for canine appendicular
osteosarcoma. Vet Comp Oncol. 7:15–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farese JP, Ashton J, Milner R, Ambrose LL
and Van Gilder J: The effect of the bisphosphonate alendronate on
viability of canine osteosarcoma cells in vitro. In Vitro Cell Dev
Biol Anim. 40:113–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schulz-Ertner D, Jäkel O and Schlegel W:
Radiation therapy with charged particles. Semin Radiat Oncol.
16:249–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schulz-Ertner D and Tsujii H: Particle
radiation therapy using proton and heavier ion beams. J Clin Oncol.
25:953–964. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tobias CA, Lyman JT, Chatterjee A, Howard
J, Maccabee HD, Raju MR, Smith AR, Sperinde JM and Welch GP:
Radiological physics characteristics of the extracted heavy ion
beams of the bevatron. Science. 174:1131–1134. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cox R, Thacker J, Goodhead DT and Munson
RJ: Mutation and inactivation of mammalian cells by various
ionising radiations. Nature. 267:425–427. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eguchi-Kasai K, Murakami M, Itsukaichi H,
Fukutsu K, Yatagai F, Kanai T, Ohara H and Sato K: Repair of DNA
double-strand breaks and cell killing by charged particles. Adv
Space Res. 22:543–549. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suzuki M, Kase Y, Yamaguchi H, Kanai T and
Ando K: Relative biological effectiveness for cell-killing effect
on various human cell lines irradiated with heavy-ion medical
accelerator in Chiba (HIMAC) carbon-ion beams. Int J Radiat Oncol
Biol Phys. 48:241–250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujisawa H, Genik PC, Kitamura H, Fujimori
A, Uesaka M and Kato TA: Comparison of human chordoma cell-kill for
290 MeV/n carbon ions versus 70 MeV protons in vitro. Radiat Oncol.
8:912013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tobias CA, Blakely EA, Alpen EL, Castro
JR, Ainsworth EJ, Curtis SB, Ngo FQ, Rodriguez A, Roots RJ,
Tenforde T and Yang TC: Molecular and cellular radiobiology of
heavy ions. Int J Radiat Oncol Biol Phys. 8:2109–2120. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hamada N, Imaoka T, Masunaga S, Ogata T,
Okayasu R, Takahashi A, Kato TA, Kobayashi Y, Ohnishi T, Ono K, et
al: Recent advances in the biology of heavy-ion cancer therapy. J
Radiat Res. 51:365–383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blakely EA, Tobias CA, Yang TC, Smith KC
and Lyman JT: Inactivation of human kidney cells by high-energy
monoenergetic heavy-ion beams. Radiat Res. 80:122–160. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsuruoka C, Suzuki M, Kanai T and Fujitaka
K: LET and ion species dependence for cell killing in normal human
skin fibroblasts. Radiat Res. 163:494–500. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kato TA, Tsuda A, Uesaka M, Fujimori A,
Kamada T, Tsujii H and Okayasu R: In vitro characterization of
cells derived from chordoma cell line U-CH1 following treatment
with X-rays, heavy ions and chemotherapeutic drugs. Radiat Oncol.
6:1162011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaser-Hotz B, Sumova A, Lomax A, Schneider
U, Klink B, Fidel J and Blattmann H: A comparison of normal tissue
complication probability of brain for proton and photon therapy of
canine nasal tumors. Vet Radiol Ultrasound. 43:480–486. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bley CR, Sumova A, Roos M and Kaser-Hotz
B: Irradiation of brain tumors in dogs with neurologic disease. J
Vet Intern Med. 19:849–854. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wada S, Van Khoa T, Kobayashi Y, Funayama
T, Ogihara K, Ueno S and Ito N: Prediction of cellular
radiosensitivity from DNA damage induced by gamma-rays and carbon
ion irradiation in canine tumor cells. J Vet Med Sci. 67:1089–1095.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maeda J, Yurkon CR, Fujisawa H, Kaneko M,
Genet SC, Roybal EJ, Rota GW, Saffer ER, Rose BJ, Hanneman WH, et
al: Genomic instability and telomere fusion of canine osteosarcoma
cells. PLoS One. 7:e433552012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji
H, Kato H, Kato S, Yamada S, Yasuda S, Ohno T, et al: Clinical
Results of Carbon Ion Radiotherapy at NIRS. J Radiat Res.
48:S1–S13. 2007. View Article : Google Scholar
|
|
24
|
Legare ME, Bush J, Ashley AK, Kato T and
Hanneman WH: Cellular and phenotypic characterization of canine
osteosarcoma cell lines. J Cancer. 2:262–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kamada T, Tsujii H, Tsuji H, Yanagi T,
Mizoe JE, Miyamoto T, Kato H, Yamada S, Morita S, Yoshikawa K, et
al: Working Group for the Bone and Soft Tissue Sarcomas: Efficacy
and safety of carbon ion radiotherapy in bone and soft tissue
sarcomas. J Clin Oncol. 20:4466–4471. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cartwright IM, Bell JJ, Maeda J, Genet MD,
Romero A, Fujii Y, Fujimori A, Kitamuta H, Kamada T, Chen DJ and
Kato TA: Effects of targeted phosphorylation site mutations in the
DNA-PKcs phosphorylation domain on low and high LET radiation
sensitivity. Oncol Lett. 9:1621–1627. 2015.PubMed/NCBI
|
|
27
|
McMillan DD, Maeda J, Bell JJ, Genet MD,
Phoonswadi G, Mann KA, Kraft SL, Kitamura H, Fujimori A and Yoshii
Y: Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron
emission. J Radiat Res. 56:784–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fakir H, Sachs RK, Stenerlöw B and Hofmann
W: Clusters of DNA double-strand breaks induced by different doses
of nitrogen ions for various LETs: Experimental measurements and
theoretical analyses. Radiat Res. 166:917–927. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hada M and Georgakilas AG: Formation of
clustered DNA damage after high-LET irradiation: A review. J Radiat
Res. 49:203–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kanai T, Endo M, Minohara S, Miyahara N,
Koyama-ito H, Tomura H, Matsufuji N, Futami Y, Fukumura A and
Hiraoka T: Biophysical characteristics of HIMAC clinical
irradiation system for heavy-ion radiation therapy. Int J Radiat
Oncol Biol Phys. 44:201–210. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paganetti H, Niemierko A, Ancukiewicz M,
Gerweck LE, Goitein M, Loeffler JS and Suit HD: Relative biological
effectiveness (RBE) values for proton beam therapy. Int J Radiat
Oncol Biol Phys. 53:407–421. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carabe A, Moteabbed M, Depauw N, Schuemann
J and Paganetti H: Range uncertainty in proton therapy due to
variable biological effectiveness. Phys Med Biol. 57:1159–1172.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsunemoto H, Morita S, Ishikawa T,
Furukawa S, Kawachi K, Kanai T, Ohara H, Kitagawa T and Inada T:
Proton therapy in Japan. Radiat Res Suppl. 8:S235–S243. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wouters BG, Lam GK, Oelfke U, Gardey K,
Durand RE and Skarsgard LD: Measurements of relative biological
effectiveness of the 70 MeV proton beam at TRIUMF using Chinese
hamster V79 cells and the high-precision cell sorter assay. Radiat
Res. 146:159–170. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tobias CA, Blakely EA, Chang PY, Lommel L
and Roots R: Response of sensitive human ataxia and resistant T-1
cell lines to accelerated heavy ions. Br J Cancer Suppl. 6:175–185.
1984.PubMed/NCBI
|
|
36
|
Loucas BD and Geard CR: Kinetics of
chromosome rejoining in normal human fibroblasts after exposure to
low- and high-LET radiations. Radiat Res. 138:352–360. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
George K, Wu H, Willingham V, Furusawa Y,
Kawata T and Cucinotta FA: High- and low-LET induced chromosome
damage in human lymphocytes: A time-course of aberrations in
metaphase and interphase. Int J Radiat Biol. 77:175–183. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Walter CU, Dernell WS, LaRue SM, Lana SE,
Lafferty MH, LaDue TA and Withrow SJ: Curative-intent radiation
therapy as a treatment modality for appendicular and axial
osteosarcoma: A preliminary retrospective evaluation of 14 dogs
with the disease. Vet Comp Oncol. 3:1–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brurberg KG, Skogmo HK, Graff BA, Olsen DR
and Rofstad EK: Fluctuations in pO2 in poorly and well-oxygenated
spontaneous canine tumors before and during fractionated radiation
therapy. Radiother Oncol. 77:220–226. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ogata T, Teshima T, Kagawa K, Hishikawa Y,
Takahashi Y, Kawaguchi A, Suzumoto Y, Nojima K, Furusawa Y and
Matsuura N: Particle irradiation suppresses metastatic potential of
cancer cells. Cancer Res. 65:113–120. 2005.PubMed/NCBI
|
|
41
|
Akino Y, Teshima T, Kihara A,
Kodera-Suzumoto Y, Inaoka M, Higashiyama S, Furusawa Y and Matsuura
N: Carbon-ion beam irradiation effectively suppresses migration and
invasion of human non-small-cell lung cancer cells. Int J Radiat
Oncol Biol Phys. 75:475–481. 2009. View Article : Google Scholar : PubMed/NCBI
|
